ArticleNeurosciences (Riyadh, Saudi Arabia)2025
Thunderclap headache management among Emergency Department visitors in tertiary care center in Makkah City: Retrospective cohort study.
Article in Neurosciences (Riyadh, Saudi Arabia), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate adherence to the guidelines in managing thunderclap headache (TCH) at King Abdullah Medical City Specialist Hospital (KAMC) in Makkah. A thunderclap headache, a severe and sudden onset headache, often signals a subarachnoid hemorrhage (SAH). The International Classification of Headache Disorders, 3rd edition (ICHD-3), recommends a diagnostic approach for TCH, including computed tomography (CT), lumbar puncture (LP), vascular studies, and magnetic resonance imagining (MRI).
methodsThis retrospective cohort study included adult patients presenting with TCH, as defined by ICHD-3, from December 2018 to June 2023. Non-probability convenience sampling was used to select patients.
resultsOf 377 initial records, 173 patients met the inclusion criteria. The mean age was 52.6 years, with males comprising 57.2%. Hypertension (39.9%) and diabetes mellitus (20.2%) were common comorbidities. Key clinical features included nausea/vomiting (41.0%) and loss of consciousness (27.7%). Compliance with ICHD-3 guidelines was 96.5%, with 99.3% undergoing CT within 6 hours. Most patients (91.3%) were diagnosed with hemorrhagic conditions, primarily SAH (85.5%), with a recovery rate of 89.2%. However, 8.1% of patients died, primarily due to complications like rebleeding and infection.
conclusionHigh adherence to ICHD-3 guidelines in TCH management led to favorable outcomes, demonstrating the effectiveness of systematic evaluation. The study highlights the importance of timely intervention and suggests that demographic factors may not significantly influence TCH outcomes. Further research should explore guideline adherence in varied settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.